Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Otolaryngology Physician in Rochester, NY
NPI: 1174788681Primary Practice Location
University Otolaryngology Associates
2365 S Clinton Ave, Rochester, NY
Primary Employer
University Otolaryngology Associates
entdoctorsphiladelphia.com
HQ Phone
Get M.D. Li-Xing's Phone Numberphone_androidMobile
Get M.D. Li-Xing's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
NY State Medical License
Perelman School of Medicine at the University of Pennsylvania
Medical School
Until 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 52 | 77 |
| 2 | 31231Diagnostic examination of nasal passages using an endoscope | 17 | 18 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 23 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 16 | 16 |
Authors: Jean Anderson Eloy, Satish Govindaraj, Eric Genden
Journal: Otolaryngol Head Neck Surg
Publication Date: 2024-09-15
Health Care Utilization and Prescribing Patterns for Adult Eustachian Tube Dysfunction.
The effect of intranasal fluticasone propionate irrigations on salivary cortisol, intraocular pressure, and posterior subcapsular cataracts in postsurgical chronic rhinosinusitis patients.
Authors: Samer Fakhri, Zachary Farhood, Amber Luong
Publication Date: 2013-03-11
Lead Sponsor: University of Rochester
Intervention / Treatment: DEVICE: Bioabsorbable steroid releasing sinus implant, DEVICE: Bioabsorbable nasal dressing impregnated with steroid
Lead Sponsor: University of Rochester
Intervention / Treatment: DRUG: oral levofloxacin, DRUG: nebulized levofloxacin
Lead Sponsor: University of Rochester
Intervention / Treatment: DRUG: Reslizumab
